Loading clinical trials...
Loading clinical trials...
This study will be conducted to evaluate the safety, tolerability, clinical activity, pharmacokinetics, and pharmacodynamics of NTLA-3001 in adults with alpha-1 antitrypsin deficiency (AATD) -associat...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Intellia Therapeutics
NCT07192705 · Non-Tuberculous Mycobacteria Pulmonary Disease, Bronchiectasis
NCT07579052 · Chronic Obstructive Pulmonary Disease
NCT06847061 · Chronic Obstructive Pulmonary Disease (COPD
NCT07572383 · Interstitial Lung Disease, Pulmonary Fibrosis
NCT05061368 · Chronic Obstructive Pulmonary Disease
New Zealand Clinical Research
Aukland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions